Clin Infect Dis. 1992 Jun;14(6):1251-3.

Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations.

Widmer AF, Gaechter A, Ochsner PE, Zimmerli W.

Source

Division of Infectious Diseases, University Hospital, Basel, Switzerland.

Abstract

The purpose of this prospective clinical study is to evaluate the role of combination chemotherapy with rifampin in the treatment of orthopedic device-related infections in which the implant could not be removed. Eleven patients with orthopedic implant-related infections due to staphylococci or streptococci were treated with the implant in situ. Each antimicrobial regimen included rifampin in combination with a beta-lactam antibiotic or ciprofloxacin. The median duration of treatment with rifampin was 86 days (range, 15-336 days) with a median follow-up of greater than 24 months after cessation of therapy. Treatment was successful for 82% of patients. Failures were associated with documented inappropriate treatment. These preliminary clinical data are supported by data from in vitro studies and animal experiments. Combination therapy with rifampin, in particular rifampin and a quinolone, should be considered for patients with orthopedic implant-related infections if the implant cannot be removed.

PMID:: 1623081; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Rifampin

LinkOut - more resources

Full Text Sources

Medical

Staphylococcal Infections - MedlinePlus Health Information

Molecular Biology Databases

RIFAMPIN - HSDB

Supplemental Content

Save items

Related citations in PubMed

Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. [JAMA. 1998]
Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group.
Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. JAMA. 1998 May 20; 279(19):1537-41.
Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. [Antimicrob Agents Chemother. 1...]
Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants.
Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Antimicrob Agents Chemother. 1993 Jun; 37(6):1214-8.
Safety and efficacy of moxifloxacin monotherapy for treatment of orthopedic implant-related staphylococcal infections. [Antimicrob Agents Chemother. 2...]
Safety and efficacy of moxifloxacin monotherapy for treatment of orthopedic implant-related staphylococcal infections.
San Juan R, Garcia-Reyne A, Caba P, Chaves F, Resines C, Llanos F, López-Medrano F, Lizasoain M, Aguado JM. Antimicrob Agents Chemother. 2010 Dec; 54(12):5161-6. Epub 2010 Sep 20.
Review [Orthopedic implant infection: prognostic factors and influence of long-term antibiotic treatment on evolution. Prospective study, 1992-1999]. [Enferm Infecc Microbiol Clin. ...]
Review [Orthopedic implant infection: prognostic factors and influence of long-term antibiotic treatment on evolution. Prospective study, 1992-1999].
Gómez J, Rodríguez M, Baños V, Martínez L, Claver MA, Ruiz J, Simarro E, Cánovas JA, Medina M, Clavel M. Enferm Infecc Microbiol Clin. 2003 May; 21(5):232-6.
Review Infections associated with orthopedic implants. [Curr Opin Infect Dis. 2006]
Review Infections associated with orthopedic implants.
Trampuz A, Widmer AF. Curr Opin Infect Dis. 2006 Aug; 19(4):349-56.

See reviews... See all...

Cited by 24 PubMed Central articles

Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. [Clin Infect Dis. 2011]
Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus.
Senneville E, Joulie D, Legout L, Valette M, Dezèque H, Beltrand E, Roselé B, d'Escrivan T, Loïez C, Caillaux M, et al. Clin Infect Dis. 2011 Aug; 53(4):334-40.
Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model. [Antimicrob Agents Chemother. 2...]
Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an experimental foreign-body infection model.
Furustrand Tafin U, Majic I, Zalila Belkhodja C, Betrisey B, Corvec S, Zimmerli W, Trampuz A. Antimicrob Agents Chemother. 2011 Oct; 55(10):4821-7. Epub 2011 Aug 1.
Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection? [Clin Orthop Relat Res. 2011]
Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection?
Leung F, Richards CJ, Garbuz DS, Masri BA, Duncan CP. Clin Orthop Relat Res. 2011 Apr; 469(4):1009-15.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Antimicrobial treatment of orthopedic implant-related infections with rifampin c...
Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations.
Clin Infect Dis. 1992 Jun ;14(6):1251-3.

PubMed
Glioblastoma multiforme with long term survival.
Glioblastoma multiforme with long term survival.
Neurol India. 2005 Sep ;53(3):329-32.

PubMed
Extending the frontiers of surgical therapy for hepatic colorectal metastases: i...
Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?
J Clin Oncol. 2005 Nov 20 ;23(33):8490-9. Epub 2005 Oct 17 .

PubMed
Intervening in the residential mobility process: neighborhood outcomes for low-i...
Intervening in the residential mobility process: neighborhood outcomes for low-income populations.
Proc Natl Acad Sci U S A. 2005 Oct 25 ;102(43):15307-12. Epub 2005 Oct 17 .

PubMed
Vascular endothelial growth factor gene therapy increases survival, promotes lun...
Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization.
Circulation. 2005 Oct 18 ;112(16):2477-86.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: